Construction of Pnpla3 I148M and Tm6sf2 E167K double mutant mouse model

Mengke WANG; Shousheng LIU; Xueru CHU; Yifen WANG; Yongning XIN

doi:10.3969/j.issn.1001-5256.2022.08.013

Volume 38 Issue 8

Aug. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(8): 1784-1789

PDF( 6045 KB)

Construction of Pnpla3 I148M and Tm6sf2 E167K double mutant mouse model

DOI: 10.3969/j.issn.1001-5256.2022.08.013

1a.
Department of Infectious Diseases, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong 266071, China
1b.
Clinical Research Center, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong 266071, China
2.
School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong 266071, China

Research funding:

National Natural Science Foundation of China (31770837)

More Information

Corresponding author: XIN Yongning, xinyongning@163.com(ORCID: 0000-0002-3692-7655)
Received Date: 2022-01-21
Accepted Date: 2022-02-25
Published Date: 2022-08-20

Abstract

Abstract

Objective To construct a Pnpla3^148M/M Tm6sf2^167K/K double mutant mouse model by crossbreeding Pnpla3^148M/M homozygous mice and Tm6sf2^167K/K homozygous mice. Methods Pnpla3^148I/M Tm6sf2^167E/K heterozygous mice were bred by hybridization of Pnpla3^148M/M Tm6sf2^167E/E and Pnpla3^148I/I Tm6sf2^167K/K homozygous mice, and the Pnpla3^148M/M Tm6sf2^167K/K mice were obtained by the self-crossbreeding of Pnpla3^148I/M Tm6sf2^167E/K mice. Male mice of Pnpla3^148M/M Tm6sf2^167K/K (n=6), Pnpla3^148M/M Tm6sf2^167E/E (n=6), and Pnpla3^148I/I Tm6sf2^167K/K (n=6) genotypes and Wt mice (n=6) were fed with normal diet for 8 weeks, and then the glucose and lipid metabolism indices were measured. A one-way analysis of variance was used for comparison between multiple groups, and the least significant difference t-test was used for further comparison bewteen two groups. Results Agarose gel electrophoresis and nucleic acid sequencing results showed that the Pnpla3^148M/M Tm6sf2^167K/K double mutant mouse model was successfully constructed. There were no significant difference in body weight between the Pnpla3^148M/M Tm6sf2^167K/K mice and the Pnpla3^148M/M Tm6sf2^167E/E, Pnpla3^148I/I Tm6sf2^167K/K, and Wt mice (all P > 0.05). The Pnpla3^148M/M Tm6sf2^167K/K mice had a significantly higher liver wet weight than the Wt mice (P < 0.05). The fasting blood glucose of Pnpla3^148M/M Tm6sf2^167K/K mice was significantly lower than that of Pnpla3^148I/I Tm6sf2^167K/K mice and Wt mice (both P < 0.05). The glucose tolerance of Pnpla3^148M/M Tm6sf2^167K/K mice was significantly reduced compared with the Pnpla3^148I/I Tm6sf2^167K/K mice (P < 0.05). There were no significant differences in insulin level between the four groups of mice (all P > 0.05). Also, there were no significant differences in the serum levels of biochemical indices between the Pnpla3^148M/M Tm6sf2^167K/K mice and the Pnpla3^148M/M Tm6sf2^167E/E, Pnpla3^148I/I Tm6sf2^167K/K, and Wt mice (all P > 0.05). Oil red O staining of the liver showed that more lipid accumulation was observed in the Pnpla3^148M/M Tm6sf2^167K/K mice than in the Pnpla3^148M/M Tm6sf2^167E/E and Wt mice. Conclusion The Pnpla3^148M/M Tm6sf2^167K/K double mutant mouse model was successfully constructed. Pnpla3 Ⅰ 148M and Tm6sf2 E 167K double mutations can cause abnormal glucose metabolism in mice.
- Non-alcoholic Fatty Liver Disease,
- Point Mutation,
- Models, Animal,
- Mice

FullText(HTML)

References(18)

References

[1]	FRIEDMAN SL, NEUSCHWANDER-TETRI BA, RINELLA M, et al. Mechanisms of NAFLD development and therapeutic strategies[J]. Nat Med, 2018, 24(7): 908-922. DOI: 10.1038/s41591-018-0104-9.
[2]	YOUNOSSI Z, ANSTEE QM, MARIETTI M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(1): 11-20. DOI: 10.1038/nrgastro.2017.109.
[3]	ARON-WISNEWSKY J, VIGLIOTTI C, WITJES J, et al. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(5): 279-297. DOI: 10.1038/s41575-020-0269-9.
[4]	WATT MJ, MIOTTO PM, de NARDO W, et al. The liver as an endocrine organ-linking NAFLD and insulin resistance[J]. Endocr Rev, 2019, 40(5): 1367-1393. DOI: 10.1210/er.2019-00034.
[5]	POWELL EE, WONG VW, RINELLA M. Non-alcoholic fatty liver disease[J]. Lancet, 2021, 397(10290): 2212-2224. DOI: 10.1016/S0140-6736(20)32511-3.
[6]	TILG H, MOSCHEN AR, RODEN M. NAFLD and diabetes mellitus[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(1): 32-42. DOI: 10.1038/nrgastro.2016.147.
[7]	TRÉPO E, ROMEO S, ZUCMAN-ROSSI J, et al. PNPLA3 gene in liver diseases[J]. J Hepatol, 2016, 65(2): 399-412. DOI: 10.1016/j.jhep.2016.03.011.
[8]	BASU RAY S. PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease[J]. Adipocyte, 2019, 8(1): 201-208. DOI: 10.1080/21623945.2019.1607423.
[9]	KOZLITINA J, SMAGRIS E, STENDER S, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease[J]. Nat Genet, 2014, 46(4): 352-356. DOI: 10.1038/ng.2901.
[10]	O'HARE EA, YANG R, YERGES-ARMSTRONG LM, et al. TM6SF2 rs58542926 impacts lipid processing in liver and small intestine[J]. Hepatology, 2017, 65(5): 1526-1542. DOI: 10.1002/hep.29021.
[11]	STEFAN N, HÄRING HU, CUSI K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies[J]. Lancet Diabetes Endocrinol, 2019, 7(4): 313-324. DOI: 10.1016/S2213-8587(18)30154-2.
[12]	IOANNOU GN. Epidemiology and risk-stratification of NAFLD-associated HCC[J]. J Hepatol, 2021, 75(6): 1476-1484. DOI: 10.1016/j.jhep.2021.08.012.
[13]	LI JF, ZHENG EQ, XIE M. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies[J]. Gene, 2019, 685: 143-148. DOI: 10.1016/j.gene.2018.11.012.
[14]	WANG X, LIU Z, WANG K, et al. Additive effects of the risk alleles of PNPLA3 and TM6SF2 on non-alcoholic fatty liver disease (NAFLD) in a Chinese population[J]. Front Genet, 2016, 7: 140. DOI: 10.3389/fgene.2016.00140.
[15]	XU M, LI Y, ZHANG S, et al. Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China[J]. Ann Hepatol, 2019, 18(3): 456-460. DOI: 10.1016/j.aohep.2018.10.005.
[16]	ZHANG J, MA XF, WANG YF, et al. Hepatocyte-specific TM6SF2 knockout aggravates hepatic steatosis in mice with nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2021, 37(11): 2612-2616. DOI: 10.3969/j.issn.1001-5256.2021.11.024. 张杰, 马学峰, 王艺奋, 等. 肝脏TM6SF2特异性敲除促进非酒精性脂肪性肝病小鼠肝脏脂肪变性[J]. 临床肝胆病杂志, 2021, 37(11): 2612-2616. DOI: 10.3969/j.issn.1001-5256.2021.11.024.
[17]	LAZARUS JV, ANSTEE QM, HAGSTRÖM H, et al. Defining comprehensive models of care for NAFLD[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(10): 717-729. DOI: 10.1038/s41575-021-00477-7.
[18]	CHEN L, DU S, LU L, et al. The additive effects of the TM6SF2 E167K and PNPLA3 I148M polymorphisms on lipid metabolism[J]. Oncotarget, 2017, 8(43): 74209-74216. DOI: 10.18632/oncotarget.18474.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(8) / Tables(3)

Get Citation

PDF

XML

Article Metrics

Article views (801) PDF downloads(50)

Construction of Pnpla3 I148M and Tm6sf2 E167K double mutant mouse model

DOI: 10.3969/j.issn.1001-5256.2022.08.013

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Construction of Pnpla3 I148M and Tm6sf2 E167K double mutant mouse model

DOI: 10.3969/j.issn.1001-5256.2022.08.013

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content